These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23938772)

  • 1. A quantitative method to identify microRNAs targeting a messenger RNA using a 3'UTR RNA affinity technique.
    Shi M; Han W; Spivack SD
    Anal Biochem; 2013 Dec; 443(1):1-12. PubMed ID: 23938772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A useful method of identifying of miRNAs which can down-regulate Zeb-2.
    Oba S; Mizutani T; Suzuki E; Nishimatsu H; Takahashi M; Ogawa Y; Kimura K; Hirata Y; Fujita T
    BMC Res Notes; 2013 Nov; 6():470. PubMed ID: 24245745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1.
    Luo Z; Wen G; Wang G; Pu X; Ye S; Xu Q; Wang W; Xiao Q
    Stem Cells; 2013 Sep; 31(9):1749-62. PubMed ID: 23765923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
    Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
    Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-181b targets Six2 and inhibits the proliferation of metanephric mesenchymal cells in vitro.
    lyu Z; Mao Z; Wang H; Fang Y; Chen T; Wan Q; Wang M; Wang N; Xiao J; Wei H; Li X; Liu Y; Zhou Q
    Biochem Biophys Res Commun; 2013 Nov; 440(4):495-501. PubMed ID: 24055707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression.
    Hurteau GJ; Carlson JA; Roos E; Brock GJ
    Cell Cycle; 2009 Jul; 8(13):2064-9. PubMed ID: 19502803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.
    Sun X; Li Y; Yu J; Pei H; Luo P; Zhang J
    Jpn J Clin Oncol; 2015 May; 45(5):474-82. PubMed ID: 25921099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microRNA‑26b and identification of its target gene EphA2 in pituitary tissues in Yanbian cattle.
    Yuan B; Yu WY; Dai LS; Gao Y; Ding Y; Yu XF; Chen J; Zhang JB
    Mol Med Rep; 2015 Oct; 12(4):5753-61. PubMed ID: 26252447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.
    Shu J; Xia Z; Li L; Liang ET; Slipek N; Shen D; Foo J; Subramanian S; Steer CJ
    RNA Biol; 2012 Oct; 9(10):1275-87. PubMed ID: 22995834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
    Majid S; Dar AA; Saini S; Deng G; Chang I; Greene K; Tanaka Y; Dahiya R; Yamamura S
    PLoS One; 2013; 8(7):e67686. PubMed ID: 23844063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.
    Hurteau GJ; Carlson JA; Spivack SD; Brock GJ
    Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.
    Tagne JB; Mohtar OR; Campbell JD; Lakshminarayanan M; Huang J; Hinds AC; Lu J; Ramirez MI
    Respir Res; 2015 Feb; 16(1):22. PubMed ID: 25763778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
    Chen ML; Liang LS; Wang XK
    Clin Exp Metastasis; 2012 Jun; 29(5):457-69. PubMed ID: 22407310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity.
    Yang W; Yee AJ
    Biochim Biophys Acta; 2014 Jul; 1843(7):1373-85. PubMed ID: 24594381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma.
    Wang Y; Yan S; Liu X; Zhang W; Li Y; Dong R; Zhang Q; Yang Q; Yuan C; Shen K; Kong B
    Oncol Rep; 2014 Apr; 31(4):1905-10. PubMed ID: 24573236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.
    Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP
    Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.